Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Benlysta review spooks investors ahead of FDA panel
Benlysta review spooks investors ahead of FDA panel
Benlysta review spooks investors ahead of FDA panel
Submitted by
admin
on November 15, 2010 - 10:48am
Source:
Fierce Biotech
News Tags:
FDA
advisory panels
Benlysta
Human Genome Sciences
lupus
Headline:
Benlysta review spooks investors ahead of FDA panel
Do Not Allow Advertisers to Use My Personal information
